Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling

Jia-Hui Hong1, Hai-Gang Zhang1

  • 1Department of Pharmacology, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, China.

Frontiers in Pharmacology
|February 21, 2022
PubMed

Insights

Transcription factors are key regulators of cardiac remodeling, a process where the heart changes structure to cope with increased workload. Understanding their roles in fetal gene reprogramming and other cellular activities is crucial for developing effective heart failure treatments.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Cardiac remodeling is a structural adaptation of the heart to increased workload.
  • Pathological cardiac remodeling can lead to heart failure.
  • The complete mechanisms underlying cardiac remodeling remain incompletely understood, hindering therapeutic development.

Purpose of the Study:

  • To review the role of transcription factors in cardiac remodeling.
  • To summarize how transcription factors regulate key cellular processes in the heart.
  • To highlight the potential of transcription factors as therapeutic targets for heart failure.

Main Methods:

  • Literature review of studies on transcription factors and cardiac remodeling.
  • Analysis of signaling pathways regulated by transcription factors.
  • Focus on transcription factor involvement in fetal gene reprogramming, energy metabolism, apoptosis, autophagy, and fibroblast activation.

Main Results:

  • Transcription factors regulate fetal gene reprogramming, energy metabolism, apoptosis, and autophagy in cardiomyocytes.
  • Transcription factors are involved in the activation of cardiac fibroblasts into myofibroblasts.
  • These regulatory roles underscore the critical involvement of transcription factors in cardiac remodeling.

Conclusions:

  • Transcription factors are crucial regulators of cardiac remodeling.
  • Targeting transcription factors offers potential for novel therapeutic strategies for heart failure.
  • Further research into transcription factor mechanisms is needed for effective drug development.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
78.7K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.7K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
87
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78